RE: Observations19 Jan 2024 15:48
D, When you see Preclinical deals being done for Billions there must be some uniqueness In whatever that attracted the Large Pharma buyer. Against a minnow like Sclp It seems like Sclp can produce what ever very good Immus, Glys, Mabs Covs. and employ very good Staff, present at the best Congresses they can. But If you can't get Large Pharma Interest, Sclp are at the mercy of every situation ie taken private or low ball buy out. IMO anymore 5Ml upfronts will
only bounce the SP 2p/3p for a month or so just as before.
Sorry to sound neg but that's the way I feel having Not sold One share since I first Invested years ago. Lucky to have two very good anchors and even with those look at the pathetic SP after all the years. . We live in hope as usual. AIMO